United States: Washington, DC
Peter Boyle heads KILPATRICK TOWNSEND & STOCKTON’s antitrust team in Washington, DC, where he works alongside fellow partners Thomas Lang, Christina Fahmy and Gwendolyn Payton. Boyle, Lang and Fahmy successfully represented Accord Healthcare in three antitrust actions challenging its reverse-payment agreement with AstraZeneca related to antipsychotic medication Seroquel, with a federal court granting Accord’s motion to dismiss in July 2022. Payton is also lead counsel for Premera Blue Cross in the Blue Cross Blue Shield antitrust litigation. Meanwhile, Fahmy and Lang helped Brookshire Grocery Store sell more than 100 in-store pharmacies to Walgreens, which received a second request from the FTC. Fahmy is also representing Cox Communications as the telecommunications provider alleges T-Mobile illegally sought to prevent it from entering the wireless market.
|Head(s) of competition
|No. WWL nominees
|Kilpatrick Townsend & Stockton
|4 partners, 3 associates
|Accord Healthcare, Smiths Medical ASD, Brookshire Grocery, Cox Communications, RaceTrac, Premera Blue Cross
Kilpatrick is trusted counsel to the world’s most innovative companies. With recognized strength in the technology sector and a full range of service offerings, we deliver practical, business-centric solutions built upon strong and enduring connections.
Kilpatrick’s Antitrust Team represents the world’s leading companies in a full range of antitrust matters, including litigating complex civil and criminal cases; defending clients in connection with government antitrust investigations; providing antitrust guidance to industry consortia, trade associations, and joint ventures; counseling and risk reduction through, among other things, the creation and implementation of compliance programs; and shepherding mergers and acquisitions through the various competition authorities around the world.
We partner with our clients to develop in-depth knowledge about their businesses and industries, which allows us to align our legal advice and strategies in the best possible way with their business goals. We have substantial experience representing companies in the life sciences, communications, high-tech, medical device, health care, retail, licensing, sports management, construction, online and digital commerce, and consumer products industries, among others.
Our team has decades of experience handling complex antitrust and competition law matters, including prior experience serving as government enforcers. We bring our collective experience to bear to help solve our clients’ antitrust challenges in an effective and efficient manner.
Track Record of Success in Civil Litigation
In civil actions, we represent national and international companies in actions brought under federal and state antitrust law, as well as matters before federal and state antitrust enforcers. Our team has delivered remarkable results in high-stakes litigation mattersfor our antitrust clients, securing victories, narrowing claims, and finding creative approaches to resolve litigation matters brought against our clients during the early stages of cases. In recent years, we have obtained numerous dismissals at the pleading stage of complex antitrust cases for clients in the pharmaceutical, medical device, automotive, telecommunications, social media, health care, and retail industries. And we have employed creative approaches to resolve antitrust claims for licensing, consumer products, and medical device clients to extricate them from cases and eliminate their risk.
Getting Deals Done
Our antitrust merger practice helps clients evaluate antitrust concerns with potential deals prior to filing, prepares them for dealing with the merger control process both in the U.S. and around the world, and ushers them through any inquiries and investigations by government enforcers. We have worked extensively with our clients in recent years to develop strategies for addressing and dealing with the changes in government enforcement policies and priorities to help salvage deals that nowadays may face greater exposure to government inquiries and challenges than they would have just a few years ago.
Counseling Clients—At the Forefront of Work That Truly Matters
We provide a wide variety of antitrust counseling services for clients in the retail/consumer products, healthcare, pharmaceutical, and other industries, among others.Our counseling work includes matters relating to competitor collaborations, effective distribution programs, pricing issues, competitor information exchange, and the recent changes in antitrust enforcement related to labor restrictions (no-poach/no-hire) and algorithmic collusion.
We are longtime counsel for several pharmaceutical industry consortia focused on helping accelerate and improve development of new medicines. Our lawyers provide critical antitrust/competition law counsel for these organizations that helps them manage risk while bringing novel initiatives to life.
We are proud to have served as antitrust counsel to several clients in the pharmaceutical industry in connection with competitor collaborations focusing on expediting vaccines and treatments for the COVID-19 virus. We helped our clients on an urgent basis to cut through the complexities and red-tape associated with establishing and managing the collaborations to enable them to focus on their efforts to develop and secure approval for vaccines and medicines aimed at saving lives during the height of the pandemic.
On the criminal side, our antitrust, white-collar crime, and investigative teams ably represent companies, individual targets of investigations, and witnesses in a variety of antitrust criminal matters. These include grand jury proceedings, amnesty and immunity negotiations, plea agreements, and trials. We conduct and coordinate investigations of criminal matters within the U.S. and throughout the world.
Peter Boyle focuses his practice on antitrust litigation and counseling matters, in particular, antitrust issues relating to intellectual property, distribution matters and industry associations. He has substantial experience litigating private treble damages actions under both federal and state antitrust laws. Mr. Boyle has handled numerous complex litigation matters implicating the overlap between the antitrust and intellectual property laws, including antitrust and economic issues arising in patent cases, such as antitrust counterclaims, misuse defenses and patent damages claims. Several of these cases required not only a reconciliation of the tensions between the IP and antitrust laws but also a sophisticated analysis of how other bodies of law and regulatory schemes, such as FDA laws and regulations, affect competition in the relevant industries.
Learn more at kilpatricktownsend.com